Israel Englander Immix Biopharma, Inc. Transaction History

Millennium Management LLC

  • $192 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$1.49 - $2.45 $7,120 - $11,708
-4,779 Reduced 18.17%
21,521 $32,000
Q2 2024

Aug 14, 2024
SELL
$1.81 - $3.06 $50,645 - $85,621
-27,981 Reduced 51.55%
26,300 $52,000
Q1 2024

May 15, 2024
BUY
$2.64 - $6.68 $143,301 - $362,597
54,281 New
54,281 $166,000

Others Institutions Holding IMMX

# of Institutions
29
Shares Held
3.33M
Call Options Held
8.9K
Put Options Held
1.2K
View Full List

About Immix Biopharma, Inc.

IMMX Quotes by TradingView
  • Ticker IMMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,910,100
  • Market Cap $27.5M
  • Description
  • Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specif...
More about IMMX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email